Bioerodible polymers for drug delivery in bone

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/30 (2006.01) A61K 9/00 (2006.01) A61K 9/20 (2006.01) A61L 24/00 (2006.01)

Patent

CA 2056384

Bioerodible polymers which degrade completely into nontoxic residues over a clinically useful period of time, including polyanhydrides, polyorthoesters,, polyglycolic acid, polylactic acid, and copolymers thereof, are used for the delivery of bioactive agents, including antibiotics, chemotherapeutic agents, inhibitors of angiogenesis, and simulators of bone growth, directly into bone.

Polymères bioérodables se dégradant complètement en résidus non toxiques sur une période de temps utile du point de vue clinique; il y a notamment les polyanhydrides, les polyorthoesters, les poly(acide glycolique), les poly(acide lactique) et leurs copolymères, utiles pour l'administration d'agents bioactifs, incluant les antibiotiques, les agents chimiothérapeutiques, les inhibiteurs de l'angiogenèse et les simulateurs de croissance osseuse administrés directement dans l'os.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Bioerodible polymers for drug delivery in bone does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bioerodible polymers for drug delivery in bone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioerodible polymers for drug delivery in bone will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2047179

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.